Related Experiment Videos
2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine
The New England Journal of Medicine
|March 18, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside.
Leukemia & lymphoma·2016
2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia.
Leukemia & lymphoma·2016
Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer.
British journal of cancer·2001
Integrin activation controls metastasis in human breast cancer.
Proceedings of the National Academy of Sciences of the United States of America·2001
Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis.
The New England journal of medicine·2026
Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.
The New England journal of medicine·2026
Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk.
The New England journal of medicine·2026
Eplontersen for Transthyretin Amyloid Cardiomyopathy.
The New England journal of medicine·2026
Myeloproliferative Neoplasms.
The New England journal of medicine·2026
Intraoperative Hemodynamic Management and Cerebral Protection During Awake Craniotomy: Evidence-Based Approaches.
Anesthesiology research and practice·2026
Combined Enzyme-Responsive Nano-Peptide Drug with Photothermal Function for Effective Anti-Hepatocellular Carcinoma in Mice Model.
International journal of nanomedicine·2026
Pathologic Complete Response to Neoadjuvant Dual Checkpoint Blockade with Durvalumab Plus Tremelimumab in Advanced-Stage HCC: A Case Report.
Journal of hepatocellular carcinoma·2026